IHH Healthcare's Outlook Still Promising
IHH Healthcare Growth Outlook
IHH Healthcare's near-term growth is expected to remain supported by continued expansion of its daycare business, with greater emphasis on quality and efficiency of care, according to CIMB Securities analyst Chun Sung Oong. Growth could also be driven by the phased reopening of Mount Elizabeth Hospital Orchard in Singapore and stronger operational synergies in India.
Operational Strategies
To manage near-term headwinds in Singapore's operations, IHH is optimizing resource utilization by directing lower-severity cases to Gleneagles Singapore and Parkway East Hospital, while the Mount Elizabeth hospitals focus on higher-intensity treatments.
Financial Outlook
Oong raises IHH's 2026-2028 core net profit estimates by 1% each. CIMB maintains a buy rating on IHH and keeps its target price at 10.30 ringgit. Shares are unchanged at 8.98 ringgit.
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.